AI Verdict
JRSH has stronger fundamentals based on our AI analysis.
JRSS vs JRSH Fundamental Comparison
| Metric | JRSS | JRSH |
|---|---|---|
| Revenue | $1.3M | $123.4M |
| Net Income | $-435,937.0 | $2.0M |
| Net Margin | -33.0% | 1.6% |
| ROE | N/A | 3.1% |
| ROA | -21.0% | 2.3% |
| Current Ratio | 0.78x | 2.79x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.01 | $0.15 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
JRSS vs JRSH: Frequently Asked Questions
Is JRSS or JRSH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), JRSH has stronger fundamentals. JRSS is rated STRONG SELL (95% confidence) while JRSH is rated SELL (78% confidence). This is not investment advice.
How does JRSS compare to JRSH fundamentally?
JRSIS HEALTH CARE Corp has ROE of N/A vs Jerash Holdings (US), Inc.'s 3.1%. Net margins are -33.0% vs 1.6% respectively.
Which stock pays higher dividends, JRSS or JRSH?
JRSS has a dividend yield of N/A or no dividend while JRSH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in JRSS or JRSH for long term?
For long-term investing, consider that JRSS has STRONG SELL rating with 95% confidence, while JRSH has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about JRSS vs JRSH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For JRSS vs JRSH, the AI consensus favors JRSH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.